Generic birth control pill could soon steal market
(Newser) -
Bayer shares tumbled to a 12-month low yesterday after a US judge ended the pharmaceutical giant's patent on Yasmin, the company’s top-selling birth control pill. The ruling means rival Barr Pharmaceuticals may introduce a lower-priced generic version of Yasmin in the next few months, Bloomberg reports.
More »
